NASDAQ:BCEL
Delisted

Atreca Stock News

etoro logo Buy BCEL
*Your capital is at risk
$0.0900
+0 (+0%)
At Close: Sep 13, 2024
SAN CARLOS, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique d
The stock price of Atreca Inc (NASDAQ: BCEL) fell by over 38% during intraday trading. This is why it happened.
Conference call and webcast scheduled for Thursday, July 29th at 8:00 a.m. ET Conference call and webcast scheduled for Thursday, July 29th at 8:00 a.m. ET
SAN CARLOS Calif., July 19, 2021 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique di

20 Short Ideas With Super-Weak Momentum

10:39am, Monday, 31'st May 2021
Often, weak stocks going into a market correction or bear move will decline faster than the main indexes. I have listed 20 stocks/ETFs out of a 4000+ sort universe experiencing a rush of selling since
SAN CARLOS Calif., May 13, 2021 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique dis
REDWOOD CITY, Calif., April 06, 2021 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics generated through a unique discovery pla
SOUTH SAN FRANCISCO, Calif., March 10, 2021 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through
SOUTH SAN FRANCISCO, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a
SOUTH SAN FRANCISCO, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a
SOUTH SAN FRANCISCO, Calif., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics generated through a unique discove
The Industrial Relations Commission has supported the government’s plan to prioritise job creation, the NSW treasurer says
Western Union, ein führendes Unternehmen im grenzüberschreitenden, währungsübergreifenden Geld- und Zahlungsverkehr, und die Western Union Foundation
Colder temperatures will usher in new concerns for struggling restaurant owners, from the end of outdoor dining to fears about the flu season. Even as indoor dining is allowed, there are caps on the n

Atreca (BCEL) Investor Presentation - Slideshow

06:05pm, Thursday, 13'th Aug 2020
The following slide deck was published by Atreca, Inc. in conjunction with this event..
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE